A Study of Actonel for the Prevention of Bone Loss

Summary

The goal of this clinical research study is to learn if Actonel (risedronate) can help to prevent the development of osteoporosis (brittle and weak bones) caused by the steroid medication used to treat leukemia. The safety of this treatment in patients with ALL or LL will also be studied.

Timeline

Start

2004-02

Primary completion

2014-08

Completion

2014-08

Drugs

Indications